Skip To Main Content
This website is intended exclusively for healthcare professionals residing and/or working in the UAE.
Campus
  • Payor
Campus
  • Payor

Inspiration and Innovation

Get inspired and stay on the cutting edge of innovation with these resources.

Sort by

Filters

Reset
  • Therapeutical Areas
  • Type of Content

Type 2 Inflammation is the underlying cause of CRSwNP in 80% of Patients.

Learn more

Lipid-lowering therapy and care gap in patients with Familial Hypercholesterolemia

Learn more

Lipid-Lowering Therapy and Achievement of Lipid Targets ESC and EAS Guidelines

Learn more

Evaluation of lipid management following ACS

Learn more

Maternal and Perinatal Outcomes of VTE

Learn more

Use of Lipid-Lowering Therapies Over 2 Years

Learn more

The European experience: Swedeheart and AIFA registries

Highlights on the most recent real-world data on the use of PCSK9 inhibitors, including those from the Swedeheart and AIFA registries.

Learn more

Perceptions and Barriers on the use of PCSK9 inhibitors

Learn more

Recurrence of VTE in Patients with Recent Gestational DVT or PE

Learn more

Clinical practice experience in patients with familial hypercholesterolemia (FH) from the Safeheart registry

Proprotein convertase subtilisin/kexin type 9 inhibitors for heterozygous familial hypercholesterolemia: A clinical practice experience from the Safeheart registry

Learn more

PCSK9 inhibitors and ACS

Learn more

How does Dupixent support lung function improvement in Pediatric Asthma?

Learn more